07
27
2015
Innovation to improve bioprocessing efficiency is in high demand and the global biopharma industry is increasing their development spending by $300 million in 2015, according to the 12th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production from BioPlan Associates.
07
24
2015
While many of us are spending the last half of the summer deciding where the nicest beaches are and who makes the best island cocktails, infectious disease scientists are looking ahead toward the next inevitable outbreak of the flu. Influenza hunters travel to hot zones that have long been the traditional breeding grounds and launching points for global seasonal pandemics. This is an important part of creating seasonal flu vaccines, which protect against only a few specific strains that researchers predict will be the most common for the upcoming year.
07
24
2015
The ability to create agents that promote tissue regeneration would have overwhelmingly beneficial implications within the clinical setting. Now, a collaboration of researchers from UT Southwestern Medical Center, Case Western Reserve University, and the University of Kentucky has identified an enzyme they say regulates tissue regeneration. The scientists believe that the inhibition of this enzyme could accelerate tissue recovery from injury, disease, or even various surgical procedures in multiple organ systems.
07
23
2015
Researchers at the CHUM Research Center and the University of Montreal report the discovery of a previously unknown link between the immune system and the death of motor neurons in Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease. The scientists believe their research paves the way to an entirely new approach for finding a drug that can cure or at least slow the progression of such neurodegenerative diseases as ALS, Alzheimer's, Parkinson's, and Huntington's diseases.
07
23
2015
The list of things that aspirin can do gets seemingly larger every year. Beyond its initial indication for the treatment of headaches and migraines, low-dose aspirin has been indicated, arguably, for patients to prevent cardiac episodes or the reoccurrence of cardiac issues in individuals who previously had a heart attack or mild stroke. Furthermore, previous studies have shown that acetylsalicylic acid (ASA), the chemical name for aspirin, blocks tumor growth in colon, gastrointestinal, and prostate cancers.
